Skip to main content

Table 2 Patient characteristics over the 10 year study period with and without ECMO patients

From: Pediatric continuous renal replacement therapy: have practice changes changed outcomes? A large single-center ten-year retrospective evaluation

Characteristic, n (%)

All patients including ECMO

All patients excluding ECMO

Patients (n)

311

273

Age (n)

 0 to 1 yr.

73 (23%)

56 (21%)

 1 to 3 yr

37 (12%)

34 (12%)

 3 to 5 yr

23 (7%)

23 (8%)

 5 to 10 yr

41 (13%)

38 (14%)

 10 to 15 yr

63 (20%)

57 (21%)

 15 to 21 yr

64 (21%)

55 (20%)

  > 21 yr

10 (3%)

10 (4%)

  Mean (SD)

8.2 (7.0)

8.4 (7.0)

Weight (n)

 0 to 10 kg

82 (26%)

64 (23%)

 10 to 20 kg

71 (23%)

68 (25%)

 20 to 50 kg

80 (26%)

68 (25%)

  > 50 kg

78 (25%)

73 (27%)

  Mean (SD)

33 (28.1)

33.5 (27.2)

Pre-existing end-stage renal disease

13 (4%)

13 (5%)

Sepsis on admission

36 (13%)

34 (14%)

Immunocompromised

 Solid organ transplant

67 (22%)

58 (21%)

 BMT

33 (11%)

31 (11%)

 Other immunocompromised

54 (17%)

51 (19%)

 Not immunocompromised

156 (50%)

132 (49%)

% Fluid overload at CRRT Start a

15 (7, 26)

15 (8, 26)

Hospital Unit of CRRT Start

 Pediatric Intensive Care Unit

257 (83%)

241 (89%)

 Neonatal Intensive Care Unit

22 (7%)

14 (5%)

 Cardiovascular Intensive Care Unit

29 (9%)

15 (6%)

 Bone Marrow Transplant Unit

1 (0.3%)

1 (0.4%)

ICU survival

154 (50%)

145 (53%)

28 day survival

176 (57%)

165 (60%)

60 day survival

156 (50%)

146 (53%)

Survival to discharge

139 (45%)

131 (48%)

Outpatient Renal Follow-up b

62 (45%)

58 (44%)

  1. aMedian with (interquartile range)
  2. bPatients who received CRRT for non-renal indications were excluded from this cohort (inborn errors of metabolism, ingestion)